0001209191-18-020971.txt : 20180320
0001209191-18-020971.hdr.sgml : 20180320
20180320183036
ACCESSION NUMBER: 0001209191-18-020971
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180319
FILED AS OF DATE: 20180320
DATE AS OF CHANGE: 20180320
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MCGRATH JOHN
CENTRAL INDEX KEY: 0001205442
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36548
FILM NUMBER: 18702930
MAIL ADDRESS:
STREET 1: 6900 PASEO PADRE PARKWAY
CITY: FREMONT
STATE: CA
ZIP: 94555
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atara Biotherapeutics, Inc.
CENTRAL INDEX KEY: 0001604464
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 460920988
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-278-8930
MAIL ADDRESS:
STREET 1: 611 GATEWAY BLVD
STREET 2: SUITE 900
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2018-03-19
0
0001604464
Atara Biotherapeutics, Inc.
ATRA
0001205442
MCGRATH JOHN
611 GATEWAY BOULEVARD
SUITE 900
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
EVP & Chief Financial Officer
Common Stock
2018-03-19
4
S
0
3000
41.99
D
91762
D
Common Stock
2018-03-20
4
S
0
3000
38.83
D
88762
D
Transaction pursuant to Rule 10b5-1 Plan adopted July 6, 2016.
The price in Column 4 is a weighted average sale price. The prices actually received ranged from $41.90 to $42.075. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
The price in Column 4 is a weighted average sale price. The prices actually received ranged from $38.50 to $39.00. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
/s/ David Tucker, Attorney-in-Fact for John F. McGrath, Jr.
2018-03-20